 | • レポートコード：GIR201104957 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、MMR（麻疹、おたふくかぜ、風疹）ワクチンの世界市場を調査対象にし、MMR（麻疹、おたふくかぜ、風疹）ワクチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（一価ワクチン、多価ワクチン）、用途別分析（免疫センター、ワクチン開発機関・組織、病院、研究所、バイオテクノロジー・バイオ医薬品企業）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Medlmmune、Emergent BioSolutions、Sanofi、Johnson & Johnson、Astellas Pharma、Merck、Pfizer、Bavarian Nordic、Serum、GlaxoSmithKline、CSL ・メーカー別販売量、売上、市場シェア ・MMR（麻疹、おたふくかぜ、風疹）ワクチンの地域別市場分析 ・MMR（麻疹、おたふくかぜ、風疹）ワクチンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・MMR（麻疹、おたふくかぜ、風疹）ワクチンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・MMR（麻疹、おたふくかぜ、風疹）ワクチンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・MMR（麻疹、おたふくかぜ、風疹）ワクチンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・MMR（麻疹、おたふくかぜ、風疹）ワクチンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・MMR（麻疹、おたふくかぜ、風疹）ワクチンの種類別市場規模2015-2020：一価ワクチン、多価ワクチン ・MMR（麻疹、おたふくかぜ、風疹）ワクチンの用途別市場規模2015-2020：免疫センター、ワクチン開発機関・組織、病院、研究所、バイオテクノロジー・バイオ医薬品企業 ・MMR（麻疹、おたふくかぜ、風疹）ワクチンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Measles, Mumps and Rubella (MMR) Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Measles, Mumps and Rubella (MMR) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Measles, Mumps and Rubella (MMR) Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Measles, Mumps and Rubella (MMR) Vaccines market has been segmented into
Monovalent Vaccine
Polyvalent Vaccine
By Application, Measles, Mumps and Rubella (MMR) Vaccines has been segmented into:
Immune Center
Vaccine Development Agencies and Organizations
Hospital
Laboratory
Biotechnology and Biopharmaceutical Companies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Measles, Mumps and Rubella (MMR) Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Measles, Mumps and Rubella (MMR) Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Measles, Mumps and Rubella (MMR) Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Measles, Mumps and Rubella (MMR) Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Measles, Mumps and Rubella (MMR) Vaccines Market Share Analysis
Measles, Mumps and Rubella (MMR) Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Measles, Mumps and Rubella (MMR) Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Measles, Mumps and Rubella (MMR) Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Measles, Mumps and Rubella (MMR) Vaccines are:
Medlmmune
Emergent BioSolutions
Sanofi
Johnson & Johnson
Astellas Pharma
Merck
Pfizer
Bavarian Nordic
Serum
GlaxoSmithKline
CSL
Among other players domestic and global, Measles, Mumps and Rubella (MMR) Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles, Mumps and Rubella (MMR) Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, with price, sales, revenue and global market share of Measles, Mumps and Rubella (MMR) Vaccines in 2018 and 2019.
Chapter 3, the Measles, Mumps and Rubella (MMR) Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles, Mumps and Rubella (MMR) Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Measles, Mumps and Rubella (MMR) Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Measles, Mumps and Rubella (MMR) Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Measles, Mumps and Rubella (MMR) Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Monovalent Vaccine
1.2.3 Polyvalent Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Immune Center
1.3.3 Vaccine Development Agencies and Organizations
1.3.4 Hospital
1.3.5 Laboratory
1.3.6 Biotechnology and Biopharmaceutical Companies
1.4 Overview of Global Measles, Mumps and Rubella (MMR) Vaccines Market
1.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medlmmune
2.1.1 Medlmmune Details
2.1.2 Medlmmune Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medlmmune SWOT Analysis
2.1.4 Medlmmune Product and Services
2.1.5 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Emergent BioSolutions
2.2.1 Emergent BioSolutions Details
2.2.2 Emergent BioSolutions Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Emergent BioSolutions SWOT Analysis
2.2.4 Emergent BioSolutions Product and Services
2.2.5 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Astellas Pharma
2.5.1 Astellas Pharma Details
2.5.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Astellas Pharma SWOT Analysis
2.5.4 Astellas Pharma Product and Services
2.5.5 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bavarian Nordic
2.8.1 Bavarian Nordic Details
2.8.2 Bavarian Nordic Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bavarian Nordic SWOT Analysis
2.8.4 Bavarian Nordic Product and Services
2.8.5 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Serum
2.9.1 Serum Details
2.9.2 Serum Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Serum SWOT Analysis
2.9.4 Serum Product and Services
2.9.5 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline SWOT Analysis
2.10.4 GlaxoSmithKline Product and Services
2.10.5 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 CSL
2.11.1 CSL Details
2.11.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 CSL SWOT Analysis
2.11.4 CSL Product and Services
2.11.5 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Measles, Mumps and Rubella (MMR) Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Measles, Mumps and Rubella (MMR) Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
6.4 France Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
7.5 India Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2015-2020)
11 Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment by Application
11.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Measles, Mumps and Rubella (MMR) Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025)
12.2.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025)
12.2.4 South America Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025)
12.3 Measles, Mumps and Rubella (MMR) Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share Forecast by Type (2021-2025)
12.4 Measles, Mumps and Rubella (MMR) Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Medlmmune Basic Information, Manufacturing Base and Competitors
Table 8. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 9. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 10. Medlmmune SWOT Analysis
Table 11. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 12. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 14. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 15. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 16. Emergent BioSolutions SWOT Analysis
Table 17. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 18. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 21. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 22. Sanofi SWOT Analysis
Table 23. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 24. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 27. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 30. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 33. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 34. Astellas Pharma SWOT Analysis
Table 35. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 36. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 39. Merck Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 42. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Pfizer Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 45. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 46. Pfizer SWOT Analysis
Table 47. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 48. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 50. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 51. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 52. Bavarian Nordic SWOT Analysis
Table 53. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 54. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Serum Basic Information, Manufacturing Base and Competitors
Table 56. Serum Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 57. Serum Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 58. Serum SWOT Analysis
Table 59. Serum Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 60. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 63. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 64. GlaxoSmithKline SWOT Analysis
Table 65. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 66. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. CSL Basic Information, Manufacturing Base and Competitors
Table 68. CSL Measles, Mumps and Rubella (MMR) Vaccines Major Business
Table 69. CSL Measles, Mumps and Rubella (MMR) Vaccines Total Revenue (USD Million) (2017-2018)
Table 70. CSL SWOT Analysis
Table 71. CSL Measles, Mumps and Rubella (MMR) Vaccines Product and Services
Table 72. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturer (2018-2019) (K Doses)
Table 74. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Regions (2015-2020) (K Doses)
Table 76. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions (2015-2020)
Table 77. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2015-2020) (K Doses)
Table 79. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2015-2020)
Table 80. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2015-2020)
Table 82. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2015-2020) (K Doses)
Table 83. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2015-2020)
Table 84. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Regions (2015-2020) (K Doses)
Table 86. Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2015-2020) (K Doses)
Table 89. South America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2015-2020)
Table 90. South America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2015-2020) (K Doses)
Table 93. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2015-2020)
Table 96. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2015-2020) (K Doses)
Table 97. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2015-2020)
Table 98. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2015-2020) (USD Million)
Table 99. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2015-2020)
Table 100. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2015-2020) (K Doses)
Table 101. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2015-2020)
Table 102. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Regions (2021-2025) (K Doses)
Table 103. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share Forecast by Regions (2021-2025)
Table 104. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2021-2025) (K Doses)
Table 105. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share Forecast by Type (2021-2025)
Table 106. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2021-2025)
Table 107. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Measles, Mumps and Rubella (MMR) Vaccines Picture
Figure 2. Global Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type in 2019
Figure 3. Monovalent Vaccine Picture
Figure 4. Polyvalent Vaccine Picture
Figure 5. Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2018
Figure 6. Immune Center Picture
Figure 7. Vaccine Development Agencies and Organizations Picture
Figure 8. Hospital Picture
Figure 9. Laboratory Picture
Figure 10. Biotechnology and Biopharmaceutical Companies Picture
Figure 11. Global Measles, Mumps and Rubella (MMR) Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturer in 2019
Figure 32. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Measles, Mumps and Rubella (MMR) Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Measles, Mumps and Rubella (MMR) Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 37. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Regions (2015-2020)
Figure 39. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Regions in 2018
Figure 40. North America Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
Figure 41. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
Figure 43. South America Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020)
Figure 45. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2015-2020)
Figure 47. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries in 2018
Figure 48. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries in 2018
Figure 50. United States Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Canada Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Mexico Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 53. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries in 2019
Figure 56. Germany Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. UK Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. France Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Russia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Italy Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 61. Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Regions 2019
Figure 64. China Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. Korea Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. India Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 69. South America Measles, Mumps and Rubella (MMR) Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries in 2019
Figure 71. South America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries in 2019
Figure 72. Brazil Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 73. Argentina Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 74. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Egypt Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. Turkey Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. South Africa Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 82. Global Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2021-2025) (K Doses)
Figure 83. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025) (K Doses)
Figure 85. Europe Sales Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025) (K Doses)
Figure 86. Asia-Pacific Sales Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025) (K Doses)
Figure 87. South America Sales Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025) (K Doses)
Figure 88. Middle East & Africa Sales Measles, Mumps and Rubella (MMR) Vaccines Market Forecast (2021-2025) (K Doses)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
牛呼吸器ワクチンの世界市場 2020年 Market Overview The global Cattle Respiratory Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cattle Respirator…- 渡航者用ワクチンの世界市場 2020年 Market Overview The Travelers Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- mRNAワクチン・治療薬の世界市場 2020年 Market Overview The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 炭疽ワクチンの世界市場 2020年 Market Overview The Anthrax Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 経口ワクチンの世界市場 2020年 Market Overview The Oral Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…